Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centers for Disease Control and Prevention - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014339
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centers for Disease Control and Prevention (CDC), a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities from expensive and dangerous health threats. It offers services in the areas of attention-deficit hyperactivity disorder, cancer, diabetes, heart disease, flu, and sexually transmitted diseases. CDC also offers laboratory safety services by conducting scientific research. The institute has collaboration with schools and universities, business, labor, public health associations, industries, international health organizations and others to prevent human health. CDC is headquartered in Atlanta, Georgia, the US.

Centers for Disease Control and Prevention – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
Centers for Disease Control and Prevention, Medical Devices Deals, 2011 to YTD 2017 10
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12
Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13
GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14
Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15
CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16
uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18
Centers for Disease Control and Prevention – Key Competitors 19
Centers for Disease Control and Prevention – Key Employees 20
Centers for Disease Control and Prevention – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Legal and Regulatory 22
May 12, 2017: AHF Affiliate AID Atlanta Files Federal Lawsuit Against CDC for Defunding Respected Longtime AIDS Service Provider 22
Jan 04, 2017: New Antimicrobial Stewardship Standard issued for US hospitals to fight antimicrobial resistance 24
Nov 11, 2016: CDC Recognizes PathGroup as First National Laboratory to Structure Cancer Pathology and Biomarker Data 25
Jul 05, 2016: FH Foundation: CDC approves diagnosis codes for Familial Hypercholesterolemia 26
Government and Public Interest 27
Sep 28, 2017: New study shows Tdap vaccination during pregnancy can prevent whooping cough in babies 27
Sep 11, 2017: Evolva awarded contract by US government to advance novel pest control product 28
Aug 08, 2017: $15 Million Grant to LSUHealthNO to Help Reduce Cancer in Louisiana 29
Aug 04, 2017: CDC invests more than $200 million to help states respond to infectious disease threats 30
Jan 20, 2017: South African Study Provides Compelling New Evidence on Role of Person-to Person Transmission in Drug-Resistant TB Epidemics 32
Dec 13, 2016: Study Finds Zika Virus Replicates and Persists in Fetal Brains and Placentas 33
Nov 29, 2016: Open-heart surgery patients notified of potential infection risk 35
Oct 24, 2016: Federal agencies express support for updated safe infant sleep recommendations 36
Oct 19, 2016: CDC recommends only two HPV shots for younger adolescents 37
Oct 06, 2016: Penn Medicine Receives CDC Award to Combat Antibiotic Resistance 38
Sep 27, 2016: CDC awards $13 million to establish the first Vector Control Unit in Puerto Rico 39
Jul 27, 2016: CDC funding accelerates antibiotic resistance efforts 40
Jul 19, 2016: American Cancer Society endorses HPV vaccine recommendations from CDC 41
Jun 27, 2016: CDC Awards $26 Million to Academic Medical Centers, Drives Innovation to Protect Patients 42
May 31, 2016: Discovery of first mcr-1 gene in E. coli bacteria found in a human in United States 43
Mar 15, 2016: APhA Supports CDC’s Efforts to Improve Patient Safety for Those Living With Chronic Pain 44
Mar 03, 2016: ICF International Awarded $35 Million Task Order with Centers for Disease Control and Prevention 45
Feb 08, 2016: New Lyme-disease-causing bacteria species discovered 46
Jan 26, 2016: HealtheConnections Receives Funding to Help Prevent and Control Chronic Disease Across Central New York 48
Product News 49
Dec 09, 2016: MVC Teamed with US CDC to develop VLP Vaccine for Dengue Disease 49
Other Significant Developments 50
Jan 11, 2017: Karmanos Cancer Institute joins nation’s leading cancer centers to endorse HPV vaccine 50
Jan 27, 2016: CSHL Joins nation’s Cancer Centers in Endorsement of HPV vaccination for Cancer Prevention 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Key Facts 2
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
Centers for Disease Control and Prevention, Deals By Therapy Area, 2011 to YTD 2017 9
Centers for Disease Control and Prevention, Medical Devices Deals, 2011 to YTD 2017 10
Centers for Disease Control and Prevention, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Abeome Enters into Research Agreement with Centers for Disease Control and Prevention 12
Synthetic Biologics Enters into Research Agreement with Centers for Disease Control and Prevention 13
GeoVax Labs Enters into Research Agreement with Centers for Disease Control and Prevention 14
Centers for Disease Control and Prevention Enters into R&D Agreement with Nanomedical Diagnostics 15
CDC Foundation Enters into Agreement with Pfizer and Centers for Disease Control and Prevention 16
uBiome Enters into Research Agreement with Centers for Disease Control and Prevention 17
Accelerate Diagnostics Enters into Co-Development Agreement with Centers for Disease Control and Prevention 18
Centers for Disease Control and Prevention, Key Competitors 19
Centers for Disease Control and Prevention, Key Employees 20
Centers for Disease Control and Prevention, Subsidiaries 21

★海外企業調査レポート[Centers for Disease Control and Prevention-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cellestia Biotech AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Cellestia Biotech AG (Cellestia Biotech) is a biopharmaceutical company that develops anti-cancer drugs for the treatment of oncology and immunological disorders. The company's lead compound includes CB-103, a novel oral pan-NOTCH inhibitor for the treatment of NOTCH dependent leukemia, lymp …
  • Adept Technology, Inc.:企業の戦略的SWOT分析
    Adept Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nimir Industrial Chemical Ltd (NICL):企業の財務・戦略的SWOT分析
    Summary Nimir Industrial Chemical Ltd (NICL) is a chemical company that manufactures and distributes oleo chemicals and chlor alkali. The company offers products such as stearic acid, soap noodles, glycerin, caustic soda, sodium hypochlorite, and hydrochloric acid, among others. It also provides raw …
  • Pharming Group NV (PHARM):企業の財務・戦略的SWOT分析
    Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Andersen Construction Co:企業の戦略的SWOT分析
    Andersen Construction Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Burger-In Oy:企業の戦略・SWOT・財務分析
    Burger-In Oy - Strategy, SWOT and Corporate Finance Report Summary Burger-In Oy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Anik Industries Ltd.:企業の戦略・SWOT・財務情報
    Anik Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Anik Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Palred Technologies Ltd:企業の戦略・SWOT・財務分析
    Palred Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Palred Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Plymouth Tube Company:企業の戦略的SWOT分析
    Plymouth Tube Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kratos Defense & Security Solutions, Inc.:戦略・SWOT・企業財務分析
    Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report Summary Kratos Defense & Security Solutions, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Alliance Healthcare Services Inc:医療機器:M&Aディール及び事業提携情報
    Summary Alliance Healthcare Services Inc (Alliance Healthcare Services) is a provider of outsourced services including diagnostic imaging services. It provides a full line of services ranging from systems, technologists to operate the systems, sales and marketing, patient scheduling and pre-authoriz …
  • Wegmans Food Markets Inc:企業の戦略的SWOT分析
    Wegmans Food Markets Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SynteractHCR Inc-製薬・医療分野:企業M&A・提携分析
    Summary SynteractHCR Inc (SynteractHCR), a subsidiary of Amulet Capital Partners LP is a contract research organization that offers clinical trials support services. The organization provides phase I – IV clinical development services, clinical services, vendor management, study document development …
  • Yoshinoya Holdings Co Ltd:企業の戦略・SWOT・財務分析
    Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yoshinoya Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • International Paper Co:戦略・SWOT・企業財務分析
    International Paper Co - Strategy, SWOT and Corporate Finance Report Summary International Paper Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Anheuser-Busch InBev SA/NV:企業の戦略・SWOT・財務情報
    Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report Summary Anheuser-Busch InBev SA/NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • ResMed Inc. (RMD)-医療機器分野:企業M&A・提携分析
    Summary ResMed Inc. (ResMed) develops, manufactures and distributes medical equipment for the diagnosis, treatment and management respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include air flow generato …
  • Ok-Q8 AB:企業の戦略的SWOT分析
    Ok-Q8 AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Central Glass Co Ltd (4044):企業の財務・戦略的SWOT分析
    Central Glass Co Ltd (4044) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Deutsche Borse AG:企業の戦略・SWOT・財務情報
    Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Borse AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆